130 related articles for article (PubMed ID: 1958593)
1. 11p deletions and breakpoints in squamous cell carcinoma: association with altered reactivity with the UM-E7 antibody.
Bradford CR; Kimmel KA; Van Dyke DL; Worsham MJ; Tilley BJ; Burk D; del Rosario F; Lutz S; Tooley R; Hayashida DJ
Genes Chromosomes Cancer; 1991 Jul; 3(4):272-82. PubMed ID: 1958593
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human laryngeal primary and metastatic squamous cell carcinoma cell lines UM-SCC-17A and UM-SCC-17B.
Carey TE; Van Dyke DL; Worsham MJ; Bradford CR; Babu VR; Schwartz DR; Hsu S; Baker SR
Cancer Res; 1989 Nov; 49(21):6098-107. PubMed ID: 2790823
[TBL] [Abstract][Full Text] [Related]
3. The E7-associated cell-surface antigen: a marker for the 11p13 chromosomal deletion associated with aniridia-Wilms tumor.
Scoggin CH; Fisher JH; Shoemaker SA; Morse H; Leigh T; Riccardi VM
Am J Hum Genet; 1985 Sep; 37(5):883-9. PubMed ID: 2996335
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody (G10) to a common antigen of human squamous cell carcinoma: binding of the antibody to the H type 2 blood group determinant.
Kimmel KA; Carey TE; Judd WJ; McClatchey KD
J Natl Cancer Inst; 1986 Jan; 76(1):9-19. PubMed ID: 2416979
[TBL] [Abstract][Full Text] [Related]
5. Altered expression in squamous carcinoma cells of an orientation restricted epithelial antigen detected by monoclonal antibody A9.
Kimmel KA; Carey TE
Cancer Res; 1986 Jul; 46(7):3614-23. PubMed ID: 3708592
[TBL] [Abstract][Full Text] [Related]
6. A fine-structure deletion map of human chromosome 11p: analysis of J1 series hybrids.
Glaser T; Housman D; Lewis WH; Gerhard D; Jones C
Somat Cell Mol Genet; 1989 Nov; 15(6):477-501. PubMed ID: 2595451
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a panel of somatic cell hybrids for subregional mapping along 11p and within band 11p13. Subdivision of the WAGR complex region.
Couillin P; Azoulay M; Henry I; Ravisé N; Grisard MC; Jeanpierre C; Barichard F; Metezeau P; Candelier JJ; Lewis W
Hum Genet; 1989 May; 82(2):171-8. PubMed ID: 2722195
[TBL] [Abstract][Full Text] [Related]
8. Evidence that loss of chromosome 18q is associated with tumor progression.
Frank CJ; McClatchey KD; Devaney KO; Carey TE
Cancer Res; 1997 Mar; 57(5):824-7. PubMed ID: 9041179
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to human squamous cell carcinoma.
Carey TE; Kimmel KA; Schwartz DR; Richter DE; Baker SR; Krause CJ
Otolaryngol Head Neck Surg; 1983 Oct; 91(5):482-91. PubMed ID: 6417595
[TBL] [Abstract][Full Text] [Related]
10. The monoclonal antibody BQ16 identifies the alpha 6 beta 4 integrin on bladder cancer.
Liebert M; Wedemeyer G; Stein JA; Washington RW; Van Waes C; Carey TE; Grossman HB
Hybridoma; 1993 Feb; 12(1):67-80. PubMed ID: 8454305
[TBL] [Abstract][Full Text] [Related]
11. Altered antigen expression predicts outcome in squamous cell carcinoma of the head and neck.
Wolf GT; Carey TE; Schmaltz SP; McClatchey KD; Poore J; Glaser L; Hayashida DJ; Hsu S
J Natl Cancer Inst; 1990 Oct; 82(19):1566-72. PubMed ID: 2119437
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic characterization, karyotype analysis and in vitro tamoxifen sensitivity of new ER-negative vulvar carcinoma cell lines, UM-SCV-1A and UM-SCV-1B.
Grénman SE; Van Dyke DL; Worsham MJ; England B; McClatchey KD; Hopkins M; Babu VR; Grénman R; Carey TE
Int J Cancer; 1990 May; 45(5):920-7. PubMed ID: 2335395
[TBL] [Abstract][Full Text] [Related]
13. The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis.
Toomes C; Jackson A; Maguire K; Wood J; Gollin S; Ishwad C; Paterson I; Prime S; Parkinson K; Bell S; Woods G; Markham A; Oliver R; Woodward R; Sloan P; Dixon M; Read A; Thakker N
Genes Chromosomes Cancer; 2003 Jun; 37(2):132-40. PubMed ID: 12696061
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody against human squamous-cell-carcinoma-associated antigen.
Tatake RJ; Amin KM; Maniar HS; Jambhekar NA; Srikhande SS; Gangal SG
Int J Cancer; 1989 Nov; 44(5):840-5. PubMed ID: 2583866
[TBL] [Abstract][Full Text] [Related]
15. Identification of new minimally lost regions on 18q in head and neck squamous cell carcinoma.
Takebayashi S; Ogawa T; Jung KY; Muallem A; Mineta H; Fisher SG; Grenman R; Carey TE
Cancer Res; 2000 Jul; 60(13):3397-403. PubMed ID: 10910046
[TBL] [Abstract][Full Text] [Related]
16. Correlation of loss of heterozygosity at 11p with tumour progression and survival in non-small cell lung cancer.
Fong KM; Zimmerman PV; Smith PJ
Genes Chromosomes Cancer; 1994 Jul; 10(3):183-9. PubMed ID: 7522041
[TBL] [Abstract][Full Text] [Related]
17. Two novel cell surface antigens on small cell lung carcinoma defined by mouse monoclonal antibodies NE-25 and PE-35.
Takahashi T; Ueda R; Song X; Nishida K; Shinzato M; Namikawa R; Ariyoshi Y; Ota K; Kato K; Nagatsu T
Cancer Res; 1986 Sep; 46(9):4770-5. PubMed ID: 3015397
[TBL] [Abstract][Full Text] [Related]
18. Sequences which flank an 11p deletion observed in an hepatocellular carcinoma map to 11p13.
Fisher JH; Scoggin CH; Rogler CE
Hum Genet; 1987 Jan; 75(1):66-9. PubMed ID: 3026949
[TBL] [Abstract][Full Text] [Related]
19. Are gains of chromosomal regions 7q and 11p important abnormalities in neuroblastoma?
Stallings RL; Howard J; Dunlop A; Mullarkey M; McDermott M; Breatnach F; O'Meara A
Cancer Genet Cytogenet; 2003 Jan; 140(2):133-7. PubMed ID: 12645651
[TBL] [Abstract][Full Text] [Related]
20. Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas.
Berenson JR; Yang J; Mickel RA
Oncogene; 1989 Sep; 4(9):1111-6. PubMed ID: 2476705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
